Analyst Jeffrey Hung of Morgan Stanley maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), retaining the price target ...

Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in ...

PTC Inc. (PTC) revealed a profit for its fourth quarter that increased from last year and beat the Street estimates. The company's ...

Vanguard Group Inc. raised its holdings in shares of PTC by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 13,740,919 shares of the technology company’s stock worth $2,596,209,000 after ...

Hedge funds and other institutional investors have recently modified their holdings of the company. Congress Asset Management Co. grew its holdings in PTC by 767.8% during the 3rd quarter.

BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal fourth-quarter earnings of $126.5 million. The Boston-based company said it had net income of $1.04 per share. Earnings, ...

PTC), changing its stock recommendation from Buy to Hold. The firm also adjusted the price target for the company's shares to $210 from a previous $196. This revision reflects concerns about the ...

US-headquartered PTC, a global software company, is looking to raise its average annual investment of $70 million in India to $100 million. The company, which has partnered with ITC Infotech for ...

The biopharmaceutical company posted revenue of $196.8 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $173.5 million. PTC Therapeutics expects full-year ...

Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

Engineering and design software provider PTC (NASDAQ:PTC ... 3D tours or interactive movies. Reviewing a company’s long-term performance can reveal insights into its business quality.